Sort   by:  
 Page size 
TranscriptomicsCD7 promotes extramedullary involvement of the B-cell acute lymphoblastic leukemia line Tanoue by enhancing integrin beta2-dependent cell adhesiveness
The Tanoue expressing firefly-luciferase gene, Luc-Tanoue, was transplanted into non-obese diabetic/severe combined immunodeficient mice, and cells infiltrated in the brain were cultured ex vivo. This process was repeated 4 times to obtain the highly invasive line Luc-Tanoue-F4. Comparison of the gl...
ORGANISM(S): Homo sapiens 
2013-12-27 | E-GEOD-53651 | biostudies-arrayexpress
UnknownFetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction.
Not available
S-EPMC10223650 | biostudies-literature
UnknownAccurate evaluation of the progress of delivery with transperineal ultrasound may improve vaginal delivery: a single-center retrospective study.
Not available
S-EPMC10684555 | biostudies-literature
UnknownA common variation in EDAR is a genetic determinant of shovel-shaped incisors.
Not available
S-EPMC2756549 | biostudies-literature
UnknownSafety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial.
Not available
S-EPMC6617029 | biostudies-literature
UnknownIdentification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker.
Not available
S-EPMC8165744 | biostudies-literature
UnknownRuxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study.
Not available
S-EPMC11588829 | biostudies-literature
UnknownLand use change and El Nino-Southern Oscillation drive decadal carbon balance shifts in Southeast Asia.
Not available
S-EPMC5861034 | biostudies-literature
UnknownLow-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
Not available
S-EPMC3024334 | biostudies-literature
UnknownRepurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.
Not available
S-EPMC8246358 | biostudies-literature
Sort   by:  
 Page size